Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

Clinical trial NCT00719680 · COMPLETED

Trial details

NCT number: NCT00719680
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency

Start date: 2008-06-01
Primary completion: 2010-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.